Lysine l ‐Lactylation: Bridging Metabolism, Chromatin and Disease
Cell Proliferation · 2026-08 · 59 (8)
DOI: 10.1111/cpr.70262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 12.07.2026. Verfasst von Anoosha Malik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Di…. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Chromatin, Lysine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Fundamental Research Funds of Zhejiang Sci-Tech University.
Abstract (Originalsprache)
Lysine L‐lactylation (K L‐la ) is a newly identified metabolite‐derived post‐translational modification that directly bridges cellular metabolic states to chromatin regulation and protein function. Mounting evidence shows that K L‐la has pivotal roles in transcription regulation and diverse cellular processes and is implicated in multiple pathophysiological conditions. This review comprehensively examines K L‐la across both histone and non‐histone substrates in biology and disease. We first illustrate the historical development of K L‐la and distinguish it from its isomers. We then delineate the enzymes regulating K L‐la , examine its crosstalk with other PTMs, and discuss its roles in cell signalling and other biological processes. Particular emphasis is placed on mechanisms through which K L‐la contributes to various human diseases such as cancer, viral infections, neurodegenerative disorders, cardiovascular conditions, metabolic abnormalities and immune dysregulation. Finally, we provide an in‐depth analysis of emerging therapeutic strategies targeting K L‐la and highlight future directions for translating mechanistic insights into clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech Univer…
- Department of Orthopaedics, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
- Department of Orthopaedic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Clinical Laboratory, Zhejiang Rehabilitation Medical Center, Hangzhou, Zhejiang, China.
- Clinical Laboratory, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
ORCID-Profile: Guiqian Chen
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- Fundamental Research Funds of Zhejiang Sci-Tech University
Zitieren
APA
Malik, A., Dilawar, M., Liao, J., Zheng, J., Qian, Q., Xu, M., Lin, S., Zhu, X., Ge, Q., Jin, L., & Chen, G. (2026). Lysine l ‐Lactylation: Bridging Metabolism, Chromatin and Disease. Cell Proliferation, 59(8). https://doi.org/10.1111/cpr.70262
Vancouver
Malik A, Dilawar M, Liao J, Zheng J, Qian Q, Xu M, et al. Lysine l ‐Lactylation: Bridging Metabolism, Chromatin and Disease. Cell Proliferation. 2026;59(8). doi:10.1111/cpr.70262
BibTeX
@article{Malik2026,
author = {Malik, Anoosha and Dilawar, Muhammad and Liao, Junguang and Zheng, Jie and Qian, Qitao and Xu, Ming and Lin, Sisi and Zhu, Xiaobo and Ge, Qiuwei and Jin, Limin and Chen, Guiqian},
title = {Lysine l ‐Lactylation: Bridging Metabolism, Chromatin and Disease},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {8},
doi = {10.1111/cpr.70262}
}
EUVIMED